Abstract
Objectives
X-ray phase contrast imaging (PCI) provides excellent image contrast by utilizing the phase shift. The introduction of microbubbles into tissues can cause a phase shift to make microbubbles visibly identified on PCI. In this study, we assessed the feasibility of targeted microbubble-based PCI for the detection of thrombosis.
Methods
The absorption and phase contrast images of P-selectin-targeted microbubbles (MBP) were obtained and compared in vitro. MBP, control IgG-targeted microbubbles (MBC), and unbound microbubbles (MBU) were tested for binding specificity on thrombi expressing P-selectin. MBP were used as molecular PCI probes to evaluate P-selectin expression in a mouse model of arteriovenous shunt thrombosis that was created using PE tubes in the bypass outside of the mouse body.
Results
PCI clearly showed the microbubbles not viewable via absorption contrast imaging (ACI). In vitro attachment of MBP (91.60 ± 11.63) to thrombi was significantly higher than attachment of MBC (17.80 ± 4.02, P < 0.001) or MBU (9.80 ± 2.59, P < 0.001). In the mouse model of arteriovenous shunt thrombosis, the binding affinity of MBP (15.50 ± 6.25) was significantly greater than that of MBC (0.50 ± 0.84, P < 0.001) or MBU (0.33 ± 0.52, P < 0.001).
Conclusions
Our results indicate that molecular PCI may be considered as a novel and promising imaging modality for the investigation of thrombosis.
Key Points
• Small thrombi are rarely detected by conventional radiography.
• Phase contrast imaging (PCI) provides higher contrast and spatial resolution than conventional radiography.
• P-selectin targeted microbubbles detected by PCI may suggest early thrombosis.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Thrombosis is a major cause of morbidity and mortality worldwide [1]. Currently available imaging modalities for the detection of thrombosis mainly include optical imaging, PET, ultrasound imaging (USI), MRI, and CT [2–10]. However, such imaging methods have difficulty detecting early thrombosis, which always presents with a relatively small thrombus. Therefore, more sensitive imaging approaches are required. Molecular imaging is an emerging field that encompasses various advanced imaging techniques using cellular and molecular biology [11–14]. Molecular imaging relies on the administration of exogenously added probes to detect and quantitatively measure the desired cellular or molecular processes in vitro and in vivo [15–18]. Microbubbles targeted to adhesion molecules, such as P-selectin, VCAM-1, and glycoprotein IIb/IIIa, have been shown to allow for real-time molecular USI of early thrombosis [13, 19, 20]. However, USI is easily disturbed by gas; therefore, USI is not an ideal imaging technique for gas-filled organs.
Conventional absorption contrast imaging (ACI) creates contrast relying on X-ray attenuation by an object. The weakly absorbing tissues are often not clearly shown by ACI. In addition to absorption, phase shift is another contrast mechanism between X-rays and tissue. By using the phase shift, phase contrast imaging (PCI) can afford more detailed images of soft tissues [21–29]. Synchrotron radiation (SR) imaging can visibly show the microvasculature due to its high resolution [30, 31]. SR-based PCI has been used for clinical mammography with its high sensitivity to soft tissues [32]. PCI has high penetration power for deep tissue detection. In addition, PCI is not disturbed by gas; therefore, PCI can be used to visualize gas-filled organs, such as lung and abdomen. Microbubbles are currently used as USI contrast agents. Moreover, microbubbles can be considered suitable contrast agents for PCI [27, 33]. Because gas has a different refractive index from that of the surrounding tissues, the gas–tissue interfaces can generate significant phase shifts that make the boundaries highly visible on PCI [29, 33, 34]. Various molecular probes (such as proteins, peptides, and antibodies) can be attached to the shell surface of microbubbles. The values of the above-mentioned applications suggest the potential for PCI to clearly show targeted microbubbles to evaluate the expression of biological targets.
In the present work, we established a mouse model of arteriovenous shunt thrombosis and imaged P-selectin expression using high-resolution PCI with microbubbles targeted to P-selectin.
Material and methods
Antibody-microbubble conjugation
Streptavidin-bound microbubbles (Targestar-SA) were obtained from Targeson (San Diego, CA, USA). The size distribution of the microbubbles was determined using a Coulter counter (AccuSizer, Santa Barbara, CA, USA). Biotinylated mouse P-selectin (553743; BD Pharmingen) and an isotype control rat IgG antibody (R3-34; BD Pharmingen) were obtained. The microbubbles were conjugated to the antibodies using a biotin-streptavidin interaction. Briefly, the Targestar-SA microbubble solution was centrifuged (400 g for 4 min) to separate the microbubbles from the liquid, and then the liquid was discarded. According to the manufacturer’s instructions, one vial of Targestar-SA can couple with approximately 100 μg of biotinylated IgG antibodies. The microbubbles were incubated with 200 μg of the respective antibodies at room temperature for 20 min. This incubation resulted in an excess of biotinylated IgG antibodies to achieve the goal of saturation all of the streptavidin binding sites on the microbubbles. The purification of conjugated microbubbles was performed via three centrifuge washes (400 g for 4 min) to remove the unbound antibodies. The conjugated microbubble concentration was determined using a Neubauer haemocytometer.
Microbubble immunofluorescence staining
FITC-labelled goat anti-rat secondary antibody (Santa Cruz Biotechnology) was used to confirm the presence of primary antibodies on the surfaces of the bound microbubbles. P-selectin-targeted microbubbles (MBP) or control IgG-targeted microbubbles (MBC) were incubated with the secondary antibody in a 1:200 ratio at room temperature for 1 h and washed with physiological saline. Unbound microbubbles (MBU) treated with only secondary antibody were used as a control. Microbubbles were placed on glass coverslips and observed under a Leica DM2500 microscope.
SR parameters
Images were acquired at the BL13W1 beamline at the Shanghai Synchrotron Radiation Facility (SSRF) in China. X-rays were generated using a 3.5 GeV electron storage ring and were monochromatized using a double-crystal monochromator with Si(111) and Si(311) crystals. The energy of the beamline could be varied from 8 to 72.5 keV. The energy resolution (△E/E) was less than 5 × 10−3. The transmitted X-rays were captured by a 100-μm-thick CdWO4 cleaved single-crystal scintillator and converted to a visible image. A high-precision sample stage that allowed for the positioning of a sample in all six axes was placed 34 m downstream of the synchrotron source. The distance between the sample stage and photon shutter was 1.7 m. The sample-to-detector distance (SDD) was changeable with a range of 8 m (Fig. 1).
Comparison between ACI and PCI
Microbubbles were placed in a PE-50 catheter that was set perpendicular to the X-ray beam. According to the imaging principles of in-line PCI, phase and absorption contrast information can be selected by changing the SDD [26, 27]. ACI can be performed with the SDD of near 0. Therefore, the SDDs for ACI and PCI were set to 5 mm and 30 cm, respectively. With the exception of SDD, all the other imaging parameters for ACI and PCI were the same. The distance was changed by moving the CCD camera on a rail. The relative densities were assessed via line profile analysis using Image-Pro Plus 6.0.
The arteriovenous shunt thrombosis model and imaging
All experiments were performed in accordance with the guidelines for the care and use of laboratory animals of Shanghai Jiao Tong University. Eighteen male C57BL/6 mice at 6 to 7 weeks of age (weighing 20 to 25 grams) were obtained from the Animal Center, CAS, Shanghai, China, and kept under pathogen-free conditions. The mice were anaesthetized before the surgical procedure via an intraperitoneal injection of ketamine (100 mg kg-1) and xylazine (10 mg kg-1). A midline incision on the neck was made under an operating microscope. The right carotid artery and left jugular vein were exposed. Two 20-cm-long PE-10 catheters connected with a 20-cm-long PE-50 catheter were used to assemble the arteriovenous shunt vessel (Fig. 2). The proximal end of an 8-mm-long silk thread was fixed in the middle of the PE-50 catheter using 502 super glue. An 8-cm-long PE-10 catheter was connected to the PE-50 catheter up to the location of the silk thread. The whole shunt vessel was filled with physiological saline without any air bubbles. One terminus of the shunt vessel was cannulated into the right carotid artery. Next, 150 μL of heparin (75 U/mL) was injected into the right carotid artery through the other terminus of the shunt vessel that was connected to a 1-mL syringe (BD). A microvascular clip was then used to temporally clamp the right carotid artery. The 1-mL syringe was removed, and the terminus of the shunt vessel was cannulated into the left jugular vein. Subsequently, the microvascular clip was removed to create arterial and venous bypasses for the blood to flow. After 25 min of blood circulation, 1 × 107 MBP, MBC, or MBU were injected into the shunt vessel through the 8-cm-long PE-10 catheter attached to a 1-mL BD syringe (injection time, 4 s). The PE-50 catheter was placed such that the silk thread was perpendicular to the X-ray beam. Imaging of the retained microbubbles was performed 10 min after the injection. The numbers of MBP, MBC, and MBU adhered onto the silk thread were calculated from the 18 mice (three groups of six mice in each group).
In vitro adhesion studies
After the thrombi were formed on the silk thread, they were daubed onto different coverslips. The coverslips were incubated with 5 × 106 MBP, MBC, or MBU. Owing to the buoyancy of the microbubbles, the coverslips were inverted to maximize the exposure of the thrombi to the microbubbles. After a 3-min static exposure, the coverslips were gently washed in physiological saline to remove the unbound microbubbles. The number of attached microbubbles was determined under a Leica optical microscope in five randomly selected fields of view (FOV). Images were obtained using a Leica Application Suite software platform. The area of the thrombi on the coverslip was at least 20 times larger than that of the FOV, so the randomly selected five FOVs were non-overlapping.
Thrombi immunohistochemistry
Immunostaining for P-selectin was performed on paraffin-embedded sections of thrombus tissue. Briefly, heat-induced epitope retrieval was performed using a pressure cooker with sodium citrate buffer. The sections were rinsed with PBS for 5 min and blocked with 5 % bovine serum albumin (BSA) for 30 min at 37 °C. The tissues were incubated using a rabbit anti mouse-CD62P primary antibody (Abcam) for 12 h at 4 °C and then incubated with an HRP-conjugated goat anti-rabbit secondary antibody (Abcam) for 1 h at room temperature. Control staining was performed using only the HRP-conjugated secondary antibody. The slides were counterstained for 5 min in haematoxylin, dehydrated, mounted, and photographed on a Leica light microscope.
Statistical analysis
The statistical package GraphPad InStat 3 was used for all analyses. The data were presented as the means ± the standard deviations (SDs). Data were analysed using one-way analysis of variance (ANOVA) followed by Bonferroni test. The differences were considered statistically significant at P < 0.05.
Results
Conjugation of the antibodies to the microbubbles and in vitro binding experiments
FITC-labelled secondary antibody was used as a probe to confirm the conjugation of P-selectin or control IgG antibodies to the microbubbles. MBP or MBC exhibited green spherical shapes after they were incubated with the green fluorescent secondary antibody (Fig. 3a, b). As shown in Fig. 3c, no evident binding-dependent fluorescence was observed on the surface of MBU. The mean diameter size of MBP was 1.94 ± 5.99 μm (Supplementary Fig. 1). After a 3-min static exposure to the thrombi, the attachment of MBP was significantly greater than that of either MBC or MBU (91.60 ± 11.63 versus 17.80 ± 4.02 versus 9.80 ± 2.59, respectively; P < 0.001; Fig. 4).
SR imaging of the microbubbles
To illustrate the advantage of PCI for imaging the microbubbles, PCI was compared with ACI. ACI and PCI were performed at an energy level of 19 keV but with two different SDDs (d = 5 mm and 30 cm, respectively). Because the density of the microbubbles was lower than that of the physiological saline, the microbubbles floated and assembled along the upper edge of the PE-50 catheter. Fig. 5a displays an MBP image taken at 5 mm. No distinct contrast between MBP and physiological saline can be detected. In comparison, PCI offered clear visualization of MBP (Fig. 5c). MBP caused a more visible change in intensity around the edges on PCI than on ACI (Fig. 5b, d). The image's clarity was determined by the resolution of the CCD. MBP were more clearly revealed by the CCD with a resolution of 325 nm than the CCD with a resolution of 3.25 μm (Supplementary Fig. 2). On PCI, the microbubbles created a phase shift variation that resulted in contrast changes around the edges of the microbubbles that appeared as light and dark fringes. The microbubbles appeared as white areas surrounded by annular black areas, which made them detectable (Supplementary Fig. 3a-c). Additionally, the microbubble diameter could be measured using line profile analysis (Image-Pro Plus 6.0), which identified both edges of a microbubble by expressing a density variation curve (Supplementary Fig. 3d, e).
PCI of P-selectin in the mouse model of arteriovenous shunt thrombosis
A mouse model of arteriovenous shunt thrombosis was successfully developed by assembling bypass blood flow between the right carotid artery and left jugular vein. The principles of the MBP attachment studies are described in Fig. 6a. After 25 min of blood circulation, some thrombi formed on the silk thread (Fig. 6b). MBP were found to specifically attach to the thrombi on the silk thread (Figs. 6d and 7a-c). P-selectin expression was confirmed on the thrombi by immunostaining (Fig. 6f, h). Few MBC or MBU were found to bind to the thrombi (Fig. 7d, e). Quantitative analysis revealed that the binding affinity of MBP was significantly greater than that of MBC or MBU (15.50 ± 6.25 versus 0.50 ± 0.84 versus 0.33 ± 0.52, respectively; P < 0.001; Fig. 7f).
Discussion
P-selectin is widely considered to be an important positive regulator during inflammatory responses [13, 17, 20, 35, 36]. The targeting of microbubbles to P-selectin has been found to greatly increase their retention within regions of thrombosis in previous studies [13, 19, 37, 38]. Microvascular retention of MBP creates strong signal enhancement on USI of inflammation and renal tissue injury [20]. Targeted contrast-enhanced USI enables noninvasive in vivo quantification and monitoring of P-selectin expression in inflammation in a murine model of chemically induced inflammatory bowel disease [39]. Similarly, we found that the binding affinity of MBP was significantly greater than that of MBC or MBU in our mouse model of arteriovenous shunt thrombosis. The competitive binding experiments to confirm MBP's binding specificity would be preferable over MBC or MBU, which may have different pharmacokinetic properties. However, the specific binding of antibody and antigen is still the most important factor affecting the binding characteristics. Using ultrasound molecular imaging (UMI), the abundant retention of these targeted microbubbles offers a strong ultrasound signal for the diagnosis of the early stages of thrombus formation [13, 20, 40]. UMI can visualize single microbubbles with picogram sensitivity [41]. However, microbubbles are required to oscillate to amplify the signal when they are used as an ultrasound contrast agent, but this is not needed in PCI [42]. By adding exposure time or X-ray energy, PCI has higher penetration power to show deep and heterogeneous as well as thick tissues.
Microbubbles have been effectively used as a contrast agent by analyser based imaging (ABI) [42–44] and X-ray dark-field imaging based on Talbot-Lau interferometry [45]. Both of these imaging modalities may be used to measure the concentration of microbubbles targeted towards biological markers. However, because the size of a microbubble is smaller than the detector pixel aperture, each single microbubble still cannot be detected independently [43]. Here, a single microbubble could be clearly shown using our in-line PCI system. This may allow the quantification of biological markers more precisely by counting the number of targeted microbubbles instead of measuring the concentration of targeted microbubbles. Because microbubbles generally contain gas and a biodegradable shell, these low-density materials absorb the synchrotron beam weakly, making microbubbles minimally identifiable with ACI. Instead, in-line PCI principally exploits phase shifts as the contrast mechanism. The gas core–tissue interface creates a significant phase shift to enhance the image contrast, causing the microbubble to stand out from its surrounding tissues. Unbound microbubbles have been used as in-line PCI contrast agents to clearly visualize the architecture of the mouse renal vasculature, hepatic vessels and tumor-associated vessels [27, 33]. However, adhesion molecules expressed on vessels cannot be evaluated using these unbound microbubbles. By attaching various molecules to the shell surface of microbubbles, the targeted microbubbles can be used as molecular probes to evaluate the expression of biological targets. Based on its high spatial resolution and sensitivity for showing microbubbles, molecular PCI may be considered a promising imaging modality to estimate the binding affinities of bound microbubbles to their targets.
There are some limitations of the present study. The detector FOV is relatively small; further technical improvements are needed to enlarge the FOV for potential clinical applications. Additionally, the thrombosis was created using PE tubes in the bypass outside of the body rather than inside the body. MBP could be clearly detected by immobilizing the PE tubes, although the exposure time lasted up to 3 s. Motion image blurring may be found in a living mouse because the exposure time is too long. To prevent potential motion artefacts in vivo, sufficient temporal resolution is expected to shorten the exposure time. Further research is required to confirm whether similar findings can be obtained inside the bodies of living mice. We only obtained projection images in this study; the image contrast became weakened because of overlap of the projection. The diameter of the microbubble can be measured by using the intensity variation. However, the method is challenged when the concentration of the microbubbles is too high. The mean size of microbubbles is always determined by measuring the diameters of a considerable number of microbubbles. However, some microbubbles cannot be detected clearly due to the overlap of the projection. In a further study, phase contrast CT may be used to avoid the overlap to measure the microbubbles more precisely.
Conclusions
Our study shows that PCI allows the clear visualization of weakly absorbing microbubbles with high spatial resolution down to the submicron scale. Targeted contrast-enhanced PCI may enable quantification of P-selectin expression to suggest early thrombosis.
References
Roger VL, Go AS, Lloyd-Jones DM et al (2011) Heart disease and stroke statistics—2011 update a report from the American Heart Association. Circulation 123:e18–e209
Anderson CR, Hu X, Tlaxca J et al (2011) Ultrasound molecular imaging of tumor angiogenesis with an integrin targeted microbubble contrast agent. Investig Radiol 46:215
Lee J-H, Huh Y-M, Y-w J et al (2007) Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nat Med 13:95–99
Ntziachristos V, Tung C-H, Bremer C, Weissleder R (2002) Fluorescence molecular tomography resolves protease activity in vivo. Nat Med 8:757–761
Phelps ME (2000) PET: the merging of biology and imaging into molecular imaging. J Nucl Med 41:661–681
Popovtzer R, Agrawal A, Kotov NA et al (2008) Targeted gold nanoparticles enable molecular CT imaging of cancer. Nano Lett 8:4593–4596
Sokolov K, Follen M, Aaron J et al (2003) Real-time vital optical imaging of precancer using anti-epidermal growth factor receptor antibodies conjugated to gold nanoparticles. Cancer Res 63:1999–2004
Wang H, Zheng L, Peng C et al (2011) Computed tomography imaging of cancer cells using acetylated dendrimer-entrapped gold nanoparticles. Biomaterials 32:2979–2988
Weissleder R, Moore A, Mahmood U et al (2000) In vivo magnetic resonance imaging of transgene expression. Nat Med 6:351–354
Willmann JK, Paulmurugan R, Chen K et al (2008) US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice 1. Radiology 246:508–518
Herschman HR (2003) Molecular imaging: looking at problems, seeing solutions. Science 302:605–608
Massoud TF, Gambhir SS (2003) Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 17:545–580
Wang X, Hagemeyer CE, Hohmann JD et al (2012) Novel single-chain antibody-targeted microbubbles for molecular ultrasound imaging of thrombosis validation of a unique noninvasive method for rapid and sensitive detection of thrombi and monitoring of success or failure of thrombolysis in mice. Circulation 125:3117–3126
Weissleder R, Pittet MJ (2008) Imaging in the era of molecular oncology. Nature 452:580–589
Briley‐Saebo KC, Mulder WJ, Mani V et al (2007) Magnetic resonance imaging of vulnerable atherosclerotic plaques: current imaging strategies and molecular imaging probes. J Magn Reson Imaging 26:460–479
Thorek DL, Chen AK, Czupryna J, Tsourkas A (2006) Superparamagnetic iron oxide nanoparticle probes for molecular imaging. Ann Biomed Eng 34:23–38
Warram JM, Sorace AG, Saini R, Umphrey HR, Zinn KR, Hoyt K (2011) A triple-targeted ultrasound contrast agent provides improved localization to tumor vasculature. J Ultrasound Med 30:921–931
Weissleder R, Tung C-H, Mahmood U, Bogdanov A (1999) In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat Biotechnol 17:375–378
Ferrante E, Pickard J, Rychak J, Klibanov A, Ley K (2009) Dual targeting improves microbubble contrast agent adhesion to VCAM-1 and P-selectin under flow. J Control Release 140:100–107
Lindner JR, Song J, Christiansen J, Klibanov AL, Xu F, Ley K (2001) Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to P-selectin. Circulation 104:2107–2112
Tang R, Chai W-M, Yang G-Y, Xie H, Chen K-M (2012) X-ray phase contrast imaging of cell isolation with super-paramagnetic microbeads. PLoS One 7:e45597
Meuli R, Hwu Y, Je JH, Margaritondo G (2004) Synchrotron radiation in radiology: radiology techniques based on synchrotron sources. Eur Radiol 14:1550–1560
Sztrókay A, Herzen J, Auweter SD et al (2013) Assessment of grating-based X-ray phase-contrast CT for differentiation of invasive ductal carcinoma and ductal carcinoma in situ in an experimental ex vivo set-up. Eur Radiol 23:381–387
Zhang X, Yang X-R, Chen Y et al (2013) Visualising liver fibrosis by phase-contrast X-ray imaging in common bile duct ligated mice. Eur Radiol 23:417–423
Tang R, Yan F, Chai WM et al (2015) A novel imaging tool for hepatic portal system using phase contrast technique with hydrogen peroxide-generated O 2 gas. J Synchrotron Radiat 22:1263–1267
Tang R, Chai W-M, Ying W et al (2012) Anti-VEGFR2-conjugated PLGA microspheres as an x-ray phase contrast agent for assessing the VEGFR2 expression. Phys Med Biol 57:3051
Tang R, Xi Y, Chai W-M et al (2011) Microbubble-based synchrotron radiation phase contrast imaging: basic study and angiography applications. Phys Med Biol 56:3503
Tang R, Huang W, Yan F et al (2013) In-line phase contrast imaging of hepatic portal vein embolization with radiolucent embolic agents in mice: a preliminary study. PLoS One 8, e80919
Tang R, Li W-X, Huang W et al (2013) CO2-based in-line phase contrast imaging of small intestine in mice. Scientific reports 3
Kobayashi S, Hori M, Dono K et al (2004) In vivo real-time microangiography of the liver in mice using synchrotron radiation. J Hepatol 40:405–408
Yuan F, Lin X, Guan Y et al (2014) Collateral circulation prevents masticatory muscle impairment in rat middle cerebral artery occlusion model. J Synchrotron Radiat 21:1314–1318
Castelli E, Tonutti M, Arfelli F et al (2011) Mammography with synchrotron radiation: first clinical experience with phase-detection technique. Radiology 259:684–694
Xi Y, Tang R, Wang Y, Zhao J (2011) Microbubbles as contrast agent for in-line x-ray phase-contrast imaging. Appl Phys Lett 99:011101
Izadifar Z, Belev G, Izadifar M, Izadifar Z, Chapman D (2014) Visualization of ultrasound induced cavitation bubbles using the synchrotron x-ray analyzer based imaging technique. Phys Med Biol 59:7541
Falati S, Liu Q, Gross P et al (2003) Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med 197:1585–1598
Burger PC, Wagner DD (2003) Platelet P-selectin facilitates atherosclerotic lesion development. Blood 101:2661–2666
Takalkar AM, Klibanov AL, Rychak JJ, Lindner JR, Ley K (2004) Binding and detachment dynamics of microbubbles targeted to P-selectin under controlled shear flow. J Control Release 96:473–482
Rychak JJ, Lindner JR, Ley K, Klibanov AL (2006) Deformable gas-filled microbubbles targeted to P-selectin. J Control Release 114:288–299
Nirupama D, Lutz AM, Ying R et al (2012) Quantification and monitoring of inflammation in murine inflammatory bowel disease with targeted contrast enhanced. Radiology 262:172–180
Lindner JR, Dayton PA, Coggins MP et al (2000) Noninvasive imaging of inflammation by ultrasound detection of phagocytosed microbubbles. Circulation 102:531–538
Alexander LK, Peter TR, Michael SH et al (2004) Detection of individual microbubbles of ultrasound contrast agents: imaging of free-floating and targeted bubbles. Investig Radiol 39:187–195
Millard TP, Endrizzi M, Everdell N et al (2015) Evaluation of microbubble contrast agents for dynamic imaging with x-ray phase contrast. Sci Rep 5
Arfelli F, Rigon L, Menk RH (2010) Microbubbles as x-ray scattering contrast agents using analyzer-based imaging. Phys Med Biol 55:1643–1658(1616)
Millard TP, Endrizzi M, Rigon L et al (2013) Quantification of microbubble concentration through x-ray phase contrast imaging. Appl Phys Lett 103:114105 - 114105-114104
Velroyen A, Bech M, Malecki A et al (2013) Microbubbles as a scattering contrast agent for grating-based x-ray dark-field imaging. Phys Med Biol 58:N37–N46(10)
Acknowledgments
The scientific guarantor of this publication is Rongbiao Tang. The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article. This study has received funding by the National Natural Science Foundation of China (Grant nos. 81301347, 81271740 and 81471808), Nation Basic Research Program of China (973 Program 2010CB834305), Shanghai Jiao Tong University Med-Science Cross Research Foundation (YG2013MS30), State Key Clinical Department of Medical Imaging and Shanghai College of first-class discipline. One of the authors has significant statistical expertise. Institutional Review Board approval was obtained. Approval from the institutional animal care committee was obtained. Methodology: prospective, experimental, performed at one institution.
Author information
Authors and Affiliations
Corresponding authors
Electronic supplementary material
Below is the link to the electronic supplementary material.
Fig. S1
Size Distribution of MBP. The mean diameter size of MBP was 1.94 ± 5.99 μm. (GIF 10 kb)
Fig. S2
Comparison of the phase contrast images attained by CCDs with the resolutions of 3.25 μm (a) and 325 nm (b). Note that MBP are more clearly visible in (b) than in (a). Some MBP (arrowheads) are detectable in (b), but hardly in (a). The images were obtained at an energy of 19 keV with an SDD of 30 cm. The exposure time was 3 s. (GIF 30 kb)
Fig. S3
Typical phase contrast image of a microbubble. A microbubble (white arrowhead in a) was first magnified twice (b) and then magnified four times (c). The microbubble appeared as a white area surrounded by an annular black area that distinguished it from the surrounding tissues. (e) Intensity variation along the blue line marked in (d). The two green arrowheads represent the diameter of the microbubble in the image. The images were obtained at an energy of 19 keV with an SDD of 30 cm. The pixel size was 325 nm × 325 nm, and the exposure time was 3 s. (GIF 39 kb)
Rights and permissions
About this article
Cite this article
Tang, R., Chai, WM., Yan, F. et al. Molecular evaluation of thrombosis using X-ray phase contrast imaging with microbubbles targeted to P-selectin in mice. Eur Radiol 26, 3253–3261 (2016). https://doi.org/10.1007/s00330-015-4129-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-015-4129-x